After tumor relapse from AAT monotherapy, only the combination of AAT and ICI could reduce vessel density, suggesting the antiangiogenic properties of ICI were non-redundant with VEGF inhibition (Allen et al., 2017). Here, SERPINA1 is linked to neoplasm.